Oncovita
Overview
Oncovita is a biotechnology company based in France, specializing in the development of innovative immunotherapies for the treatment of cancer. The company focuses on leveraging cutting-edge viral vector technologies to develop treatments that boost the immune system's ability to fight cancer.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Oncovita in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.